Robert Faturechi

Reporter

Photo of Robert Faturechi

Robert Faturechi is a reporter at ProPublica. He has written about how the rich avoid taxes, industry lobbying campaigns to block safety standards, conflicts of interest within government, self-dealing by political consultants and corporate donors targeting state elections officials. He broke stories on Sen. Richard Burr selling stock before the coronavirus market crash.

In 2020, he and two colleagues won the Pulitzer Prize for national reporting for a series of stories about avoidable deaths in the Navy and Marine Corps, and the failure of top commanders to heed warnings that could have saved lives.

His reporting has resulted in congressional hearings, new legislation, federal indictments and widespread reforms.

Before joining ProPublica, he was a reporter at The Los Angeles Times, where his work exposed inmate abuse, cronyism, secret cop cliques and wrongful jailings at the LA County Sheriff’s Department. He obtained an unprecedented cache of confidential personnel records that showed the agency knowingly hired dozens of cops with histories of serious misconduct. His stories helped lead to sweeping reforms at the nation’s largest jail system, criminal convictions of sheriff’s deputies and the resignation of the sheriff.

You can send him story tips and documents through email at [email protected] or on Signal/WhatsApp at (213) 271-7217.

Trump’s Mine-Safety Nominee Ran Coal Firm Cited for Illegal Employment Practices

Records show the coal mining company formerly run by David Zatezalo retaliated against a foreman who complained of harassment and unsafe conditions.

House Democrats Push for Tougher Oversight of Regulators’ Conflicts of Interest

A bill was introduced following reports by ProPublica and The New York Times that disclosed the industry ties of Trump officials tasked with loosening rules covering the workplace, consumer protection and the environment.

Can Police Prevent the Next Charlottesville?

“We saw it coming,” said a Virginia officer, but they couldn’t stop it. Still, law enforcement experts say measures can be taken — even when protesters are armed.

Secrecy and Suspicion Surround Trump’s Deregulation Teams

ProPublica and The New York Times identify more possible conflicts of interest among appointees, as Democrats in Congress demand greater transparency from the White House.

Trump Has Secretive Teams to Roll Back Regulations, Led by Hires With Deep Industry Ties

We’ve found many appointees with potential conflicts of interest, including two who might personally profit if particular regulations are undone.

Help Us Identify the Officials Helping Trump Roll Back Regulations

In February, President Trump ordered federal agencies to form task forces charged with finding regulations to weaken or eliminate. While the names of appointees to executive-agency task forces are typically made public, some agencies are refusing to reveal who is on their panels

Tom Price Bought Drug Stocks. Then He Pushed Pharma’s Agenda in Australia.

Before he was named Trump’s health secretary, Price took a congressional trip to Australia and pressed officials to extend protections for drug companies in an international trade agreement.

Tom Price Intervened on Rule That Would Hurt Drug Profits, the Same Day He Acquired Drug Stock

While in Congress, HHS Secretary Tom Price acted to help kill a rule that would hurt drug company profits shortly after his broker bought him up to $90,000 worth of pharmaceutical stock.

Democratic Senators Ask Jeff Sessions to Explain Preet Bharara Firing

The lawmakers cited a ProPublica report that U.S. Attorney Bharara was investigating HHS Secretary Tom Price when the Trump administration reversed course and removed him.

Fired U.S. Attorney Preet Bharara Said to Have Been Investigating HHS Secretary Tom Price

Trump’s head of the Department of Health and Human Services traded stocks of health-related companies while working on legislation affecting the firms. A source says Bharara was overseeing an investigation. The White House didn't immediately comment.

When a Study Cast Doubt on a Heart Pill, the Drug Company Turned to Tom Price

After hearing from a company whose CEO was a campaign contributor, a congressional aide to Donald Trump’s HHS nominee repeatedly pushed a federal health agency to remove a critical drug study from its website.

Conservatives Plot Their Course on the Rising ‘Sea of Red’ in State Capitals

Meeting in private, enthused activists promise that the growing Republican dominance in state government will unleash a wave of laws to cut business taxes, restrict unions and expand school privatization.

The Continuing Muddle at a Pro-Trump Political Committee

‘America Comes First’ can’t seem to decide if it’s a PAC or a super PAC, but in either case its federal filings remain problematic.

Pro-Trump Group Blew by Basic Campaign Finance Laws

The America Comes First PAC did not disclose its donors before Election Day. And its top funder is banned from the securities industry.

Meet the Candidate For Attorney General Who’s Hunted Quail with Corporate Donors

Donald Trump has bashed “puppets” who court the Koch brothers. A Kansas official on his shortlist for U.S. attorney general shot pheasant and clay pigeons with one of their lobbyists.

Clay Pigeons: How Lobbyists Secretly Woo Top Election Officials

Secretaries of state, who oversee ballot measures on topics from gun control to the minimum wage, are increasingly courted by interest groups and industries with billions of dollars at stake.

Super PAC to Billionaire: We Need More Money to Save a Republican Senate

An errant email from a PAC supporting Sen. Pat Toomey of Pennsylvania highlights Republican anxiety: “Trump has taken a real hit this week.”

Follow ProPublica

Latest Stories from ProPublica